Effect of recalibration of the hs-TnT assay on diagnostic performance.

*Corresponding author: Jillian R. Tate, Chemical Pathology, Pathology Queensland, Block 7, Level 3, Royal Brisbane and Women’s Hospital, Herston Road, Herston, QLD 4029, Australia, Phone: +61 7 36460082, Fax: +61 7 36463417, E-mail: [email protected] William A. Parsonage: Department of Cardiology, Royal Brisbane and Women’s Hospital, Brisbane, QLD, Australia; and School of Medicine, University of Queensland, Brisbane, QLD, Australia Jaimi H. Greenslade and Christopher J. Hammett: Department of Emergency Medicine, Royal Brisbane and Women’s Hospital, Brisbane, QLD, Australia; and School of Public Health, Queensland University of Technology, Brisbane, QLD, Australia Jacobus P.J. Ungerer and Carel J. Pretorius: Pathology Queensland, Brisbane, QLD, Australia Anthony F.T. Brown: School of Medicine, University of Queensland, Brisbane, QLD, Australia; and Department of Emergency Medicine, Royal Brisbane and Women’s Hospital, Brisbane, QLD, Australia Louise Cullen: School of Medicine, University of Queensland, Brisbane, QLD, Australia; Department of Emergency Medicine, Royal Brisbane and Women’s Hospital, Brisbane, QLD, Australia; and School of Public Health, Queensland University of Technology, Brisbane, QLD, Australia